![View Jim Faulkner, PhD](https://oribiotech-com.nimbus-cdn.uk/wp-content/uploads/2023/11/Jim-Faulkner-160x160.png?format=webp&nv=e620130e-1fcb-4adf-875f-03b3d695bdfc)
Jim Faulkner, PhD.
Scientific Advisor
Jim is a highly experienced biopharmaceutical development leader with specialist skills in gene and cell therapy. Recognized for taking more than 25 different medicines into the clinic, including multiple CAR-T assets, Jim currently serves as Chief Technology Officer at Ascidian Therapeutics and was SVP, Product Delivery for Autolus Ltd, a clinical-stage CAR-T company spun out of University College London. Responsible for process development, technical operations, engineering and supply chain, Jim served on the leadership team that took Autolus from start-up to successful IPO in three years.